Table of Contents Author Guidelines Submit a Manuscript
Journal of Aging Research
Volume 2014, Article ID 897671, 8 pages
http://dx.doi.org/10.1155/2014/897671
Research Article

Effect of Dementia on the Use of Drugs for Secondary Prevention of Ischemic Heart Disease

1Division of General Internal Medicine, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA
2Department of Health Policy and Management, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA
3Center for Bioethics and Health Law, University of Pittsburgh, Pittsburgh, PA 15260, USA
4College of Medicine, Drexel University, Philadelphia, PA 19129, USA
5Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA
6Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA
7Department of Neurology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA

Received 24 September 2013; Accepted 6 January 2014; Published 25 February 2014

Academic Editor: F. Richard Ferraro

Copyright © 2014 Nicole R. Fowler et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Maslow, “Dementia and serious coexisting medical conditions: a double whammy,” Nursing Clinics of North America, vol. 39, no. 3, pp. 561–579, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. D. J. Brauner, J. C. Muir, and G. A. Sachs, “Treating nondementia illnesses in patients with dementia,” The Journal of the American Medical Association, vol. 283, no. 24, pp. 3230–3235, 2000. View at Google Scholar · View at Scopus
  3. R. S. Tilvis, M. H. Kähönen-Väre, J. Jolkkonen, J. Valvanne, K. H. Pitkala, and T. E. Strandberg, “Predictors of cognitive decline and mortality of aged people over a 10-year period,” Journals of Gerontology A, vol. 59, no. 3, pp. 268–274, 2004. View at Google Scholar · View at Scopus
  4. T. J. Bunch, J. P. Weiss, B. G. Crandall et al., “Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia,” Heart Rhythm, vol. 7, no. 4, pp. 433–437, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Hofman, A. Ott, M. M. B. Breteler et al., “Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study,” The Lancet, vol. 349, no. 9046, pp. 151–154, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. P. B. Rosenberg, M. M. Mielke, J. Tschanz et al., “Effects of cardiovascular medications on rate of functional decline in alzheimer disease,” American Journal of Geriatric Psychiatry, vol. 16, no. 11, pp. 883–892, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Jick, G. L. Zornberg, S. S. Jick, S. Seshadri, and D. A. Drachman, “Statins and the risk of dementia,” The Lancet, vol. 356, no. 9242, pp. 1627–1631, 2000. View at Google Scholar · View at Scopus
  8. E. Zamrini, G. McGwin, and J. M. Roseman, “Association between statin use and Alzheimer's disease,” Neuroepidemiology, vol. 23, no. 1-2, pp. 94–98, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. F. A. Sloan, J. G. Trogdon, L. H. Curtis, and K. A. Schulman, “The effect of dementia on outcomes and process of care for medicare beneficiaries admitted with acute myocardial infarction,” Journal of the American Geriatrics Society, vol. 52, no. 2, pp. 173–181, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. K. E. Schmader, J. T. Hanlon, G. G. Fillenbaum, M. Huber, C. Pieper, and R. Horner, “Medication use patterns among demented, cognitively impaired and cognitively intact community-dwelling elderly people,” Age and Ageing, vol. 27, no. 4, pp. 493–501, 1998. View at Google Scholar · View at Scopus
  11. E. G. Rodriguez, H. H. Dodge, M. A. Birzescu et al., “Use of lipid-lowering drugs in older adults with and without dementia: a community-based epidemiological study,” Journal of the American Geriatrics Society, vol. 50, pp. 1852–1856, 2002. View at Google Scholar
  12. F. Landi, G. Gambassi, K. L. Lapane et al., “Comorbidity and drug use in cognitively impaired elderly living in long-term care,” Dementia and Geriatric Cognitive Disorders, vol. 9, no. 6, pp. 347–356, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. L. P. Fried, N. O. Borhani, P. Enright et al., “The cardiovascular Health Study: design and rationale,” Annals of Epidemiology, vol. 1, no. 3, pp. 263–276, 1991. View at Google Scholar · View at Scopus
  14. O. L. Lopez, L. Kuller, A. L. Fitzpatrick, D. Ives, J. T. Becker, and N. Beauchamp, “Evaluation of dementia in the Cardiovascular Health Cognition Study,” Neuroepidemiology, vol. 22, no. 1, pp. 1–12, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. M. F. Folstein, S. E. Folstein, and P. R. McHugh, “Mini-mental state: a practical method for grading the cognitive state of patients for the clinician,” Journal of Psychiatric Research, vol. 12, pp. 189–198, 1975. View at Google Scholar
  16. D. Wechsler, WAIS-R Manual, Psychological Corporation, New York, NY, USA, 1981.
  17. A. F. Jorm and P. A. Jacomb, “The informant questionnaire on cognitive decline in the elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms,” Psychological Medicine, vol. 19, no. 4, pp. 1015–1022, 1989. View at Google Scholar · View at Scopus
  18. C. Kawas, J. Segal, W. F. Stewart, M. Corrada, and L. J. Thal, “A validation study of the dementia questionnaire,” Archives of Neurology, vol. 51, no. 9, pp. 901–906, 1994. View at Google Scholar · View at Scopus
  19. A. L. Fitzpatrick, L. H. Kuller, D. G. Ives et al., “Incidence and prevalence of dementia in the Cardiovascular Health Study,” Journal of the American Geriatrics Society, vol. 52, no. 2, pp. 195–204, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. B. M. Psaty, L. H. Kuller, D. Bild et al., “Methods of assessing prevalent cardiovascular disease in the cardiovascular health study,” Annals of Epidemiology, vol. 5, no. 4, pp. 270–277, 1995. View at Publisher · View at Google Scholar · View at Scopus
  21. B. M. Psaty, M. Lee, P. J. Savage et al., “Assessing the use of medications in the elderly: methods and initial experience in the cardiovascular health study,” Journal of Clinical Epidemiology, vol. 45, no. 6, pp. 683–692, 1992. View at Publisher · View at Google Scholar · View at Scopus
  22. C. V. Pollack Jr. and W. B. Gibler, “2000 ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a practical summary for emergency physicians,” Annals of Emergency Medicine, vol. 38, no. 3, pp. 229–240, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Smith S.C., S. N. Blair, R. O. Bonow et al., “AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the american heart association and the american college of cardiology,” Circulation, vol. 104, no. 13, pp. 1577–1579, 2001. View at Google Scholar · View at Scopus
  24. T. J. Ryan, J. L. Anderson, E. M. Antman et al., “ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction),” Journal of the American College of Cardiology, vol. 28, no. 5, pp. 1328–1428, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. S. A. Hunt, W. T. Abraham, M. H. Chin et al., “ACC/AHA guidelines for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Evaluation and Management of Heart Failure),” Journal of the American College of Cardiology, vol. 46, pp. 1116–1143, 2005. View at Google Scholar
  26. M. Boustani, B. Peterson, L. Hanson, R. Harris, and K. N. Lohr, “Screening for dementia in primary care: a summary of the evidence for the U.S. preventive services task force,” Annals of Internal Medicine, vol. 138, no. 11, pp. 927–I60, 2003. View at Google Scholar · View at Scopus
  27. C. M. Callahan, H. C. Hendrie, and W. M. Tierney, “Documentation and evaluation of cognitive impairment in elderly primary care patients,” Annals of Internal Medicine, vol. 122, no. 6, pp. 422–429, 1995. View at Google Scholar · View at Scopus
  28. N. Campbell, M. Boustani, E. N. Skopelja et al., “Medication adherence in older adults with cognitive impairment: a systematic evidence-based review,” American Journal of Geriatric Pharmacotherapy, vol. 10, no. 3, p. 165177, 2012. View at Publisher · View at Google Scholar
  29. J. A. Rhymes, L. B. McCullough, R. J. Luchi, T. A. Teasdale, and N. Wilson, “Withdrawing very low-burden interventions in chronically ill patients,” The Journal of the American Medical Association, vol. 283, no. 8, pp. 1061–1063, 2000. View at Google Scholar · View at Scopus
  30. N. Li, A. Lee, R. A. Whitmer et al., “Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis,” British Medical Journal, vol. 340, Article ID b5465, 2010. View at Google Scholar
  31. C. T. Thorpe, J. M. Thorpe, A. J. Kind, C. M. Bartels, C. M. Everett, and M. A. Smith, “Receipt of monitoring of diabetes mellitus in older adults with comorbid dementia,” Journal of the American Geriatrics Society, vol. 60, no. 4, pp. 644–651, 2012. View at Google Scholar
  32. R. A. Morrison and L. A. Siu, “A comparison of pain and its treatment in advanced dementia and cognitively intact patients with hip fracture,” Journal of Pain and Symptom Management, vol. 19, no. 4, pp. 240–248, 2000. View at Google Scholar